- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03732404
Oral Preoperative Carbohydrate on Early Postoperative Outcome After Cesarean Section
August 6, 2021 updated by: hany farouk, Aswan University Hospital
Effects of Oral Preoperative Carbohydrate on Early Postoperative Outcome After Cesarean Section. A Double-Blind Placebo-controlled Study
Preoperative carbohydrate treatments have been widely adopted as part of enhanced recovery after surgery (ERAS) or fast-track surgery protocols.
Although fast-track surgery protocols have been widely investigated and have been shown to be associated with improved postoperative outcomes, some individual constituents of these protocols, including preoperative carbohydrate treatment, have not been subject to such robust analysis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Carbohydrate (sugar-containing) nutritional supplements have become a routine part of the package of care for people undergoing planned surgical procedures.
the investigator wanted to discover whether carbohydrate supplements are a useful part of care packages used by doctors to improve recovery after planned cesarean section.
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aswan, Egypt, 81528
- Aswan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant women undergoing elective caesarean section
- Term gestational age (37+0 to 41+6 weeks)
- Singleton gestation
Exclusion Criteria:
- Women with gestational diabetes and diabetes mellitus
- Fetal intrauterine growth restriction
- Ante-natally detected congenital anomaly which will require admission to the neonatal nursery
- Women who received steroids within the past 7 days prior to delivery
- Women who did not complete a gestational diabetes screening test
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: preoperative carbohydrate loading
Patients in the treatment group will receive a carbohydrate beverage (total carbohydrates equal to 12.6g/100 mL: 2.1 g monosaccharide, 10.0 g maltodextrin; 240 mOsm/L) in a dose of 800 mL.
Patients will be free to drink the beverage from the evening before the operation and up to 2 hours before the induction of anesthesia
|
Patients in the treatment group will receive a carbohydrate beverage (total carbohydrates equal to 12.6g/100 mL: 2.1 g monosaccharide, 10.0 g maltodextrin; 240 mOsm/L) in a dose of 800 mL.
Patients will be free to drink the beverage from the evening before the operation and up to 2 hours before the induction of anesthesia
Other Names:
|
Placebo Comparator: Placebo
The control group will receive plain water with the same volume and timing of treatment
|
The control group will receive plain water with the same volume and timing of treatment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of hospital stay
Time Frame: 3 weeks
|
Number of days in the hospital for each participant between the groups.
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of participants experienced nausea
Time Frame: 24 hours postoperative
|
Number of participants experienced nausea
|
24 hours postoperative
|
Change in preoperative well-being assessment from baseline to one hour using the 100 millimeter (mm) visual analogue scale
Time Frame: ist 24 hours postoperative
|
100 mm visual analogue scales for hunger, thirst, anxiety, fatigue and nausea administered on the morning of surgery prior to morning beverage consumption and 60 minutes after the beverage.
All measurements will be assessed using the same scale starting at 0 to 100mm with 0 being the worst and 100 being the best and average being 85.
|
ist 24 hours postoperative
|
neonatal blood glucose concentration at four and ten hours of age
Time Frame: 24 hours post operative
|
measure neonatal blood glucose level at four and ten hours of age
|
24 hours post operative
|
Neonates with plasma glucose level of less than 45 mg/dL between the groups
Time Frame: ist 24 hours postoperative
|
First umbilical cord blood sample will be taken for plasma glucose level of less than 45 mg/dL to note hypoglycemia between the groups.
|
ist 24 hours postoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2018
Primary Completion (Actual)
June 30, 2021
Study Completion (Actual)
August 1, 2021
Study Registration Dates
First Submitted
November 3, 2018
First Submitted That Met QC Criteria
November 5, 2018
First Posted (Actual)
November 6, 2018
Study Record Updates
Last Update Posted (Actual)
August 9, 2021
Last Update Submitted That Met QC Criteria
August 6, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- aswu/197/7/18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section Complications
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
University of CalgaryNot yet recruitingCesarean Section ComplicationsCanada
-
Peking University People's HospitalNot yet recruiting
-
Gaziosmanpasa Research and Education HospitalUnknownCesarean Section ComplicationsTurkey
-
Ain Shams UniversityUnknownCesarean Section ComplicationsEgypt
-
Mohamed Abdelrady MohamedCompletedCesarean Section ComplicationsEgypt
-
McGill University Health Centre/Research Institute...Thammasat UniversityUnknownCesarean Section ComplicationsCanada
Clinical Trials on preoperative carbohydrate loading
-
Eunah Cho, MDCompletedGeneral AnesthesiaKorea, Republic of
-
Armed Police Force Hospital, NepalCompleted
-
Medical University of GdanskRecruitingBariatric Surgery | Carbohydrate LoadingPoland
-
University of ArizonaNova BiomedicalRecruitingCesarean Section | Enhanced Recovery After SurgeryUnited States
-
Karamanoğlu Mehmetbey UniversityCompletedQuality of Life | Postoperative Pain | Breastfeeding | Postoperative NauseaTurkey
-
University of FloridaHeermann Anesthesia FoundationCompleted
-
Thomas Jefferson UniversityRecruitingKidney Diseases | Pain, Postoperative | Postoperative Complications | Postoperative Nausea and Vomiting | Opioid UseUnited States
-
Bezmialem Vakif UniversityRecruiting
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Pomeranian Medical University SzczecinUnknownPostoperative Nausea and VomitingPoland